Kerala

AOC

Goods

Medicines

e-tender for the procurement of Anti Haemophilia drugs for the year 2021-22

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 25 Mar 2021Closed

Bids

5 Bids26 Feb 2022

#	Company	Amount	Rank	Status
1	L1₹11.0 CrAccepted-AOC	₹11.0 Cr	L1	Accepted-AOC Details in notice
2	L1Rejected-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	-	L1	Rejected-Finance Details in notice(rate Hike)
3	Rejected-Technical	-	-	Rejected-Technical Details in notice
4	Rejected-Technical CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 \| AHMADABAD \| GUJARAT \| 380054	-	-	Rejected-Technical Details in notice
5	Rejected-Technical DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R 282 ITC AREA OF MIDC THANE BELAPUR ROAD RABALE NAVI MUMBAI 400701 \| NAVI MUMBAI \| THANE \| MAHARASHTRA \| 400701	-	-	Rejected-Technical Details in notice

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

25 Mar 2021, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL thycaud, Thiruvananthapuram

Work Description

e-tender for the procurement of Anti Haemophilia drugs for the year 2021-22

Tender Information

Tender ID

2021_KMSCL_415837_1

Reference Number

KMSCL/ED/HAEM/RC/2021/005

Tender Type

Open Tender

Product Category

Medicines

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

32 documents required · 32 mandatory

Fee/PreQual/Technical

RequiredCheck List in Aneexure - I (.pdf)

RequiredThe details of offline EMD submitted as DD/BG if applicable (.pdf)

RequiredThe details of Re-inspection fee as per sl no 3 of Anx.1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.xls)

Requirednotary attested copy of Annual turnover statement as per sl no 7 of Anx 1 (.pdf)

RequiredNotary attested copy of manufacturing license as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested photocopies of valid import license as per sl no 9 of Anx 1 (.pdf)

RequiredNotary attested copy of product wise market standing certificate as per sl no 10 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license for the sale of drugs imported as per the sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy valid WHO-GMP Certificate as per the sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid COPP as per the sl no. 13 of Anx 1 (.pdf)

RequiredNotary attested copy of PMF Approval Certificate as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant documents as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of statement fomat given in Anx V as per the sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant document as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of statement on viral detection test in the format in Anx VI (.pdf)

RequiredNotary attested copy of relevent documents to prove the purity of the offered product (.pdf)

RequiredNotary attested copy of purity of the offered products as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested copy of relevent documents as per sl no 21 of Anx 1 (.pdf)

RequiredNotary attested copy of details of batches tested in NIB as per sl no 22 of Anx 1 (.pdf)

Requirednotary attested copy of statement of supply quoted items as per sl no 23 of Anx 1 (.pdf)

RequiredNotary attested documents to prove the supply of quoted items as per sl no 24 of Anx 1 (.pdf)

RequiredNotary attested copy of Current Non-conviction certificate as per sl no 25 of Anx 1 (.pdf)

RequiredNotary attested atatement of manufacture and imported drugs as per sl no 26 of Anx 1 (.pdf)

Requirednotary attested copy of Power of Attorney/Resolution of Board (.pdf)

RequiredNotary attested copy of undertaking/declaration as per sl no 28 of Anx 1 (.pdf)

Requirednotary attested copy of Audited Balance Sheets and P and L statement for three years (.pdf)

Requirednotary attested details of technical personnel as per sl no 30 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per the sl no 31 of Anx 1 (.pdf)

Finance

RequiredPrice bid Format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Pre-Bid Meeting

Meeting Place

Online Platform

Important Dates

Last Activity

26 Feb 2022

Published

16 Feb 2021

Bid Opening

31 Mar 2021

Download Starts

16 Feb 2021

Download Ends

25 Mar 2021

Submission Starts

16 Feb 2021

Clarification Period

16 Feb 2021 - 25 Mar 2021

Pre-Bid Meeting

20 Feb 2021

BOQ Preview

•

HUMAN ANTI HAEMOPHILIC FACTOR IX 600 IU

•

HUMAN ANTI HAEMOPHILIC FACTOR VIII 250 IU

•

ANTI HAEMOPHILIC FACTOR VII 1 mg (50,000 IU)

•

ANTI HAEMOPHILIC FACTOR VIII with VON WILLIBRAND FACTOR 250 IU (contains Factor VIII 250 IU along with minimum 50% of VWF)

•

FACTOR VIII INHIBITOR BYPASSING AGENT (FEIBA) 500 IU

•

Novo Nordisk India Private Limited

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.05 MB

Technical Bid Opening

tech_bid_open.pdf

PDF

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

fin_bid_open.pdf

PDF

boq_comp_chart.xlsx

xlsx

Financial Evaluation

fin_eval.pdf

PDF

Award of Contract

aoc.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

Ready to Participate?

Download all tender documents and submit your bid